Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a healthcare technology company that completed its business combination with LifeSci Acquisition Corp., a blank-check company sponsored by LifeSci Capital, in 2021. The SPAC originally priced its IPO in 2020, targeting the life sciences and healthcare technology sector. Science 37 operates a decentralized clinical trial platform designed to enable pharmaceutical and biotechnology sponsors to conduct trials outside traditional research sites. The company filed an 8-K with the SEC on November 29, 2023, disclosing a material corporate event. SNCE has traded on Nasdaq since the close of its de-SPAC transaction. Sign up for SpacDesk to access the full filing history, sponsor profiles, and post-merger performance data for SNCE and hundreds of other SPAC transactions.